Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Close this folder2. Rational use of medicines
View the document2.1 The relationship between evidence and rational use
View the document2.2 Other influences on the choice of medicines
View the document2.3 Sources of information for prescribers
View the document2.4 The special role of drug bulletins
View the document2.5 Specific ways in which bulletins can help
View the document2.6 Bulletins as part of wider initiatives for promoting rational use of medicines
View the document2.7 Summary
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information
 

2.2 Other influences on the choice of medicines

Many other factors affect the choice of treatments. They include a lack of access to independent information, availability of medicines, cost, culture and politics. For example, even if a practitioner could be aware of all the 'scientific' data, a particular treatment option may be inappropriate in a local community if the product is not locally available, is too expensive, or its use clashes with local practice or customs. In deciding on a particular treatment, practitioners need to consider the alternative approaches available (including no treatment), and the evidence on the comparative benefit/harm balance of the alternatives, together with local customs, costs and resources.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014